Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of &agr;1&bgr;1 integrin receptor inhibitors and TGF-&bgr;1 inhibitors in the treatment of kidney disease

Use of &agr;1&bgr;1 integrin receptor inhibitors and TGF-&bgr;1 inhibitors in the treatment of kidney disease

US Patent 6492325 · Granted Dec 10, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RAC1 inhibitors for the treatment of Alport glomerular disease2020
RAC1 inhibitors for the treatment of alport glomerular disease2017
Inducible ligand for α1β1 integrin and uses2010
Inducible ligand for α1β1 integrin and uses2008
Genetically engineered mice containing alterations in the MHC class II genes1997